EDWARDS LIFESCIENCES CORP holding history
As of Nov. 6, 2026 (UTC)
| March 31, 2025 | 2,611,789 | $189,302,467 | 1.37% | Withheld — Comparison unavailable: Comparable change withheld pending corporate-action review | May 14, 2025 |
| June 30, 2025 | 2,223,704 | $173,915,890 | 1.21% | Withheld — Comparison unavailable: Comparable change withheld pending corporate-action review | Aug. 12, 2025 |
| Sept. 30, 2025 | 2,114,537 | $164,447,542 | 1.24% | Withheld — Comparison unavailable: Comparable change withheld pending corporate-action review | Nov. 12, 2025 |
| Dec. 31, 2025 | 1,734,212 | $147,841,573 | 1.50% | Withheld — Comparison unavailable: Comparable change withheld pending corporate-action review | Feb. 13, 2026 |
| March 31, 2026 | 1,033,497 | $82,762,440 | 1.05% | Withheld — Comparison unavailable: Comparable change withheld pending corporate-action review | May 13, 2026 |
| June 30, 2026 | 346,640 | $31,357,054 | 0.81% | Withheld — Comparison unavailable: Comparable change withheld pending corporate-action review | Aug. 12, 2026 |
6 rows · Sort by column; scroll horizontally for more.
No rows match these filters.
Schedule 13G disclosures
No verified related disclosures are included in this freeze.
About reported holdings
13F reports quarter-end securities, excluding cash and shorts. Position changes do not establish trades, motives or returns; portfolio weights use disclosed 13F value.